The EU is making more comprehensive checks on vaccines before approval, which means a slower rollout of shots than former EU member Britain and growing public frustration.
The issue has been exacerbated by Anglo-Swedish AstraZeneca and Pfizer of the United States both announcing delivery hold-ups in recent weeks.
“We regret the continued lack of clarity...